Actively Recruiting
Delirium Reduction With Ramelteon
Led by Centennial Medical Center · Updated on 2024-08-22
506
Participants Needed
1
Research Sites
140 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The overall purpose of this study is to identify a medication that might treat and/or prevent delirium in intensive care unit (ICU). Currently, there is no proven medical therapy for prevention or treatment of delirium. Ramelteon is a medication approved for insomnia. We hypothesize that ramelteon may help regulate the day/night cycle and decrease ICU delirium.
CONDITIONS
Official Title
Delirium Reduction With Ramelteon
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Medical or surgical ICU patient
- Ability to take oral or nasogastric tube medication within 48 hours of ICU admission
- Expected ICU length of stay and life expectancy of at least 48 hours
- Patient or legally authorized representative capable of signing informed consent within 48 hours of ICU admission
You will not qualify if you...
- History of cirrhosis
- Active alcohol withdrawal
- Taking fluvoxamine before admission
- Known allergy or hypersensitivity to ramelteon
- Incarcerated individuals
- Pregnancy
- Acute neurological conditions such as brain abscess, head bleed, or meningitis
- Transferred from another hospital where patient stayed more than 4 days
- Non-English speaking patients
- Hearing impairment requiring sign language
- Visual impairment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centennial Medical Center
Nashville, Tennessee, United States, 37205
Actively Recruiting
Research Team
J
Jennifer Johnson, MD
CONTACT
C
Chelsea Mitchell, PharmD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here